Bordet Scientific Publications

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.

Jhaveri KL, Neven P, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, O'Shaughnessy J, Harbeck N, Carey LA, Curigliano G, Llombart-Cussac A, Lim E, García Tinoco ML, Sohn J, Mattar A, Zhang Q, Huang CS, Hung CC, Martinez Rodriguez JL, Ruíz Borrego M, Nakamura R, Pradhan KR, Cramer von Laue C, Barrett E, Cao S, Wang XA, Smyth LM, Bidard FC

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey.

Fontaine C, Libert I, Echterbille MA, Bonhomme V, Botterman J, Bourgonjon B, Brouillard V, Courtin Y, De Buck J, Debruyne PR, Delaat M, Delperdange JM, Duck L, Everaert E, Lamot C, Holbrechts S, Lossignol D, Krekelbergh F, Langenaeken C, Lapeire L, Naert E, Lauwers K, Matic M, Mebis J, Miedema G, Pieterbourg M, Plehiers B, Punie K, Roblain F, Schrijvers D, Serre CH, Vandenborre K, Broecke AV, Van den Bulk H, Vanopdenbosch L, Van Ryckeghem F, Verheezen J, Verschaeve V, Voordeckers M, Klastersky J

Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey.

Case Report: A Rare Location of Recurrent Ameloblastoma.

Yech-Chou M, Javadian R, De Saint Aubain N, Bouland C, Yanni A, Boutremans E, Dequanter D

Case Report: A Rare Location of Recurrent Ameloblastoma.

Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast Cancer.

Agostinetto E, Caballero C, Ignatiadis M, Pop CF

Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast Cancer.

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Bordet Scientific Publications